Medicare Part D coverage expansion: The proposed CMS rule allowing Medicare Part D plans to cover anti-obesity medications would make 31 million Medicare beneficiaries with obesity eligible for semaglutide and tirzepatide, representing a USD 55.8 billion annual drug spend potential at 15% initial penetration
Orders over $200 ship free
Most have no idea of this information about NNT and are told "we will see if it helps" not knowing that most have effects close to or less than placebo
Constipation, bloating, and occasional vomiting happen too
Resistance training is particularly beneficial for preserving muscle mass, which supports long-term metabolic health and thermogenesis
Whats more, GLP-1s cause people to eat less, so you may be skimping on nutrients that are important for bone health, such as calcium and vitamin D